Understanding Non-Stimulant ADHD Medications
When most people think of ADHD medication, they think of stimulants — Adderall, Ritalin, Vyvanse. And for good reason: stimulant medications are the most researched and most commonly prescribed ADHD treatments, working effectively for roughly 70-80% of patients.
But stimulants aren't the right fit for everyone. Some people experience side effects they can't tolerate. Others have medical conditions that make stimulants risky. And some simply prefer a non-stimulant approach.
The good news: there are several FDA-approved non-stimulant medications that can meaningfully improve ADHD symptoms. This guide covers what they are, how they work, and who they may be best for.
Why Consider a Non-Stimulant?
Your provider may recommend a non-stimulant medication if you:
- Can't tolerate stimulant side effects — appetite loss, insomnia, anxiety, jitteriness, or elevated heart rate
- Have a history of substance use disorder — non-stimulants have no abuse or diversion potential
- Have cardiovascular concerns — certain heart conditions make stimulants risky
- Experience rebound effects — the "crash" when stimulants wear off
- Have co-occurring anxiety — stimulants can sometimes worsen anxiety; some non-stimulants actually help it
- Need 24-hour coverage — non-stimulants typically work around the clock, not just during "on" hours
- Prefer a non-controlled substance — non-stimulants aren't Schedule II, making prescriptions and refills simpler
FDA-Approved Non-Stimulant ADHD Medications
Atomoxetine
Atomoxetine was the first FDA-approved non-stimulant for ADHD (2002). It works by selectively blocking the norepinephrine reuptake transporter in the prefrontal cortex, increasing norepinephrine availability — a neurotransmitter critical for attention, impulse control, and executive function.
Atomoxetine also has evidence for reducing anxiety symptoms, making it a strong choice when ADHD and anxiety co-occur. Generic versions are widely available and affordable.
Viloxazine Extended-Release
Viloxazine ER is the newest FDA-approved ADHD medication, approved for children in 2021 and adults in 2022. It's a selective norepinephrine reuptake inhibitor (similar to atomoxetine) but also modulates serotonin receptors, giving it a unique pharmacologic profile.
Because viloxazine affects both norepinephrine and serotonin, it may be particularly helpful for patients with co-occurring depression or emotional dysregulation. It's still brand-name only, so cost may be a factor without insurance coverage.
Guanfacine Extended-Release
Guanfacine ER is an alpha-2A adrenergic agonist — it works by stimulating receptors in the prefrontal cortex that strengthen neural connections involved in attention, working memory, and impulse control. Originally developed for blood pressure, its cognitive benefits led to FDA approval for ADHD.
Guanfacine is FDA-approved for children aged 6-17 and commonly used off-label in adults. It's particularly effective for the hyperactive/impulsive symptoms of ADHD and emotional reactivity. It's often used alongside a stimulant to smooth out coverage or address remaining symptoms — this combination is well-studied and generally well-tolerated.
Clonidine Extended-Release
Clonidine ER, like guanfacine, is an alpha-2 adrenergic agonist — but it's less selective, acting on alpha-2A, 2B, and 2C receptors. This means it's generally more sedating than guanfacine. It's FDA-approved for ADHD in children aged 6-17 and used off-label in adults.
The sedating effect of clonidine, while a side effect, can be therapeutic for patients with ADHD who also struggle with insomnia. Bedtime dosing can improve sleep onset while providing next-day ADHD symptom coverage. It's also useful when ADHD co-occurs with tic disorders.
Off-Label Options
In addition to FDA-approved non-stimulants, some medications are used off-label for ADHD when first-line options aren't ideal:
Bupropion (Wellbutrin)
Bupropion is an antidepressant that increases both norepinephrine and dopamine — the same neurotransmitters targeted by stimulant medications. While not FDA-approved for ADHD, it has modest evidence for improving attention and concentration. It's most useful when ADHD co-occurs with depression, as it treats both conditions simultaneously. It also doesn't cause weight gain or sexual side effects, common concerns with other antidepressants.
Modafinil (Provigil)
Modafinil is a wakefulness-promoting agent approved for narcolepsy and shift work sleep disorder. Some providers prescribe it off-label for ADHD, particularly for adults who need improved alertness and focus but can't tolerate traditional ADHD medications. Evidence is mixed, and it's a Schedule IV controlled substance.
Stimulants vs. Non-Stimulants: How They Compare
| Feature | Stimulants | Non-Stimulants |
|---|---|---|
| Time to work | 30-60 minutes | 2-6 weeks |
| Duration | 4-14 hours (varies by formulation) | 24 hours (continuous) |
| Effectiveness | Works for ~70-80% of patients | Works for ~40-60% of patients |
| Abuse potential | Schedule II controlled substance | None (not controlled) |
| Appetite effects | Commonly suppresses appetite | Mild or none |
| Sleep effects | Can cause insomnia | May cause drowsiness (can help sleep) |
| Anxiety effects | Can worsen anxiety | May improve anxiety (atomoxetine, viloxazine) |
| Prescription refills | Typically no refills; new Rx each month | Standard refills allowed |
What to Expect When Starting a Non-Stimulant
If you and your provider decide a non-stimulant is right for you, here's what the process typically looks like:
- Low starting dose — Most non-stimulants start at a low dose and gradually increase over 2-4 weeks to minimize side effects
- Patience is key — Unlike stimulants (which work the first day), non-stimulants need time. Don't judge effectiveness until you've been at your target dose for at least 2-3 weeks
- Track your symptoms — Your provider may ask you to use a rating scale or journal to monitor changes in focus, impulsivity, and emotional regulation
- Follow-up appointments — Expect check-ins every 2-4 weeks during the adjustment period to fine-tune your dose
- Don't stop abruptly — Some non-stimulants (especially guanfacine and clonidine) should be tapered gradually to avoid rebound effects. Always follow your provider's instructions for stopping
Finding the Right Medication for You
There's no universal "best" ADHD medication — the right choice depends on your specific symptoms, medical history, lifestyle, and goals. Some patients try 2-3 medications before finding the best fit. This is normal and not a sign that treatment isn't working — it's part of finding your optimal regimen.
Factors your provider will consider include:
- Your primary ADHD symptoms (inattention vs. hyperactivity/impulsivity vs. both)
- Co-occurring conditions (anxiety, depression, insomnia, substance use history)
- Previous medication trials and why they did or didn't work
- Your daily schedule and when you need symptom coverage most
- Insurance coverage and cost considerations
- Your comfort level with controlled vs. non-controlled substances
At EnnHealth Psychiatry, Dr. Michel takes a comprehensive approach to ADHD treatment — starting with a thorough 60-minute evaluation to understand your unique presentation, then working with you to find the medication (or combination) that provides the best symptom relief with the fewest side effects.
Exploring Your ADHD Treatment Options?
Schedule a telehealth evaluation to discuss whether non-stimulant medications may be right for you. Available in 30+ states.
Book Your Evaluation